|
|
Volumn 13, Issue 1, 2002, Pages 35-39
|
|
Glycoprotein IIb/IIIa combination therapy in acute myocardial infarction: Tailoring therapies to optimize outcome
|
|
Author keywords
Acute myocardial infarction; Fibrinolysis; Glycoprotein IIb IIIa inhibitors
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTITHROMBIN;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENOXAPARIN;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
RETEPLASE;
STREPTOKINASE;
TENECTEPLASE;
THROMBIN;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
ACUTE HEART INFARCTION;
ADJUVANT THERAPY;
BLEEDING;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY THROMBOSIS;
DOSE RESPONSE;
DRUG ERUPTION;
DRUG EXPOSURE;
DRUG POTENCY;
FIBRINOLYTIC THERAPY;
GERIATRIC PATIENT;
HEART MUSCLE BLOOD FLOW;
HEART MUSCLE REPERFUSION;
HEART REINFARCTION;
HUMAN;
MORTALITY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
REVIEW;
ST SEGMENT ELEVATION;
THROMBOCYTE;
TISSUE LEVEL;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ALGORITHM;
COMPARATIVE STUDY;
DRUG COMBINATION;
HEART INFARCTION;
ALGORITHMS;
ANTIBODIES, MONOCLONAL;
COMPARATIVE STUDY;
DRUG THERAPY, COMBINATION;
ENOXAPARIN;
HUMAN;
IMMUNOGLOBULINS, FAB;
MYOCARDIAL INFARCTION;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
TREATMENT OUTCOME;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
|
|
EID: 0035985003
PISSN: 09295305
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1015316108557 Document Type: Review |
|
Times cited : (4)
|
|
References (21)
|
